Literature DB >> 6338852

Hyperthyroidism due to thyrotropin-secreting pituitary tumors. Diagnostic and therapeutic considerations.

R C Smallridge, C E Smith.   

Abstract

Hyperthyroidism may be caused by the inappropriate secretion of thyroid-stimulating hormone (TSH) from a pituitary tumor. Of 33 reported cases, 17 have occurred in women and 16 have occurred in men. All patients had large tumors, and secretion of a second hormone (growth hormone or prolactin) has been common. Diagnosis requires the detection of TSH in the serum when patients are clinically and biochemically hyperthyroid. Ancillary tests supporting the diagnosis include an alpha-subunit to TSH molar ratio greater than 1.0, an absent TSH response to protirelin, suppression of serum TSH (but not alpha-subunit) by glucocorticoids, and a lack of suppression of serum TSH by dopaminergic agonists. Successful treatment of this disorder requires pituitary surgery and/or pituitary irradiation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338852

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.

Authors:  M P Fischler; W H Reinhart
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

2.  Severe hyperthyroidism due to neoplastic TSH hypersecretion in an old man.

Authors:  D Rubello; B Busnardo; M E Girelli; M Piccolo
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

3.  In vitro studies on TSH secretion and adenylate cyclase activity in a human TSH-secreting pituitary adenoma. Effects of somatostatin and dopamine.

Authors:  A Spada; M Bassetti; E Martino; G Giannattasio; P Beck-Peccoz; A Sartorio; L Vallar; L Baschieri; A Pinchera; G Faglia
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

4.  Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion.

Authors:  S W Lamberts; R Oosterom; T Verleun; E P Krenning; H Assies
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

5.  Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide.

Authors:  S M Orme; J T Lamb; M Nelson; P E Belchetz
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.